» Journals » Cardiol Clin

Cardiology Clinics

Cardiology Clinics is a reputable medical journal that focuses on the latest advancements, research, and clinical practices in the field of cardiology. It provides comprehensive reviews and expert insights on various cardiovascular diseases, diagnostic techniques, treatment options, and preventive measures. With contributions from renowned cardiologists and researchers, this journal serves as a valuable resource for healthcare professionals seeking to enhance their knowledge and improve patient care in the ever-evolving field of cardiology.

Details
Abbr. Cardiol Clin
Publisher Elsevier
Start 1983
End Continuing
Frequency Four no. a year
p-ISSN 0733-8651
e-ISSN 1558-2264
Country Netherlands
Language English
Metrics
h-index / Ranks: 5907 62
SJR / Ranks: 5939 736
CiteScore / Ranks: 6529 4.10
JIF / Ranks: 4480 2.4
Recent Articles
11.
Makwana B, Malode A, Khadke S, Patel V, Shah R, Patel M, et al.
Cardiol Clin . 2024 Nov; 43(1):151-167. PMID: 39551556
Immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy have revolutionized cancer treatment but can cause life-threatening cardiovascular toxicities through immune-related adverse events. Myocarditis is the most common and potentially...
12.
Raddatz M, Pershad Y, Parker A, Bick A
Cardiol Clin . 2024 Nov; 43(1):13-23. PMID: 39551555
Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related phenomenon in which somatic mutations lead to clonal expansion of hematopoietic stem cells without the development of hematologic abnormalities. A growing...
13.
Zaghlol R, Pedersen L, Qamer S, Yoo S, Ladin D, Parvathaneni A, et al.
Cardiol Clin . 2024 Nov; 43(1):129-149. PMID: 39551554
Radiation therapy is a critical component in managing many malignancies by improving local control and survival. The benefits of radiation may come at the expense of unintended radiation injury to...
14.
Balough E, Ariza A, Asnani A, Hoeger C
Cardiol Clin . 2024 Nov; 43(1):111-127. PMID: 39551553
Anthracycline chemotherapy is associated with cardiotoxicity, predominantly manifesting as left ventricular systolic dysfunction within the first year of treatment. Early detection is possible through biomarkers and cardiovascular imaging before clinical...
15.
Makram O, Nain P, Vasbinder A, Weintraub N, Guha A
Cardiol Clin . 2024 Nov; 43(1):1-11. PMID: 39551552
This review goes beyond traditional approaches in cardio-oncology, highlighting often-neglected factors impacting patient care. Social determinants, environment, health care access, and gut microbiome significantly influence patient outcomes. Powerful tools like...
16.
Tobis J
Cardiol Clin . 2024 Sep; 42(4):xi. PMID: 39322348
No abstract available.
17.
Ravi D, Parikh R, Aboulhosn J, Tobis J
Cardiol Clin . 2024 Sep; 42(4):559-571. PMID: 39322346
Patent foramen ovale (PFO) may be an underlying factor in the pathogenesis of migraine, vasospastic angina, and Takotsubo cardiomyopathy. This article reviews the role that PFO may play in each...
18.
Meier B
Cardiol Clin . 2024 Sep; 42(4):547-557. PMID: 39322345
The patent foramen ovale (PFO) jeopardizes health and its problems may be major. A nineteenth century case report was the first description of a PFO as cause of death. To...
19.
Piayda K, Bertog S, Mbai M, Sharma A, Veulemans V, Sievert H
Cardiol Clin . 2024 Sep; 42(4):537-545. PMID: 39322344
Percutaneous PFO closure is a well-established medical procedure to mitigate paradoxic embolism and the future risk of stroke in a well-selected patient clientele. When it comes to procedural guidance during...
20.
Nagraj S, Palaiodimos L
Cardiol Clin . 2024 Sep; 42(4):525-536. PMID: 39322343
Presence of patent foramen ovale (PFO), particularly if high-grade, increases the risk of decompression illness (DCI) and its severe forms. In unprovoked or recurrent DCI, neurologic, cutaneous, or cardiopulmonary DCI,...